Coughlin Christopher's Insider Trades & SAST Disclosures
Coughlin Christopher's most recent trade in Timken Co. was a trade of 269 Common Stock done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Coughlin Christopher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 269 | 103,317 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 269 | 7,881 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.61 per share. | 27 Feb 2025 | 269 | 103,048 (0%) | 0% | 82.6 | 22,222 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 18,155 | 110,227 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 12,225 | 12,225 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 8,150 | 8,150 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.61 per share. | 13 Feb 2025 | 7,179 | 103,048 (0%) | 0% | 82.6 | 593,057 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,212 | 92,636 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 1,788 | 90,880 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.06 per share. | 10 Feb 2025 | 564 | 92,072 (0%) | 0% | 82.1 | 46,282 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.06 per share. | 10 Feb 2025 | 456 | 90,424 (0%) | 0% | 82.1 | 37,419 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2025 | 1,969 | 89,594 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2025 | 1,734 | 88,067 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.15 per share. | 08 Feb 2025 | 502 | 89,092 (0%) | 0% | 81.1 | 40,737 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.15 per share. | 08 Feb 2025 | 442 | 87,625 (0%) | 0% | 81.1 | 35,868 | Common Stock |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 497 | 6,800 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Purchase of securities on an exchange or from another person at price $ 59.44 per share. | 16 Dec 2024 | 10,000 | 36,357 (0%) | 0% | 59.4 | 594,400 | Common Stock |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 402 | 26,357 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 452 | 25,955 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 2,916 | 25,503 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Sale of securities on an exchange or to another person at price $ 76.74 per share. | 14 May 2024 | 878 | 0 (0%) | 0% | 76.7 | 67,382 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.35 per share. | 02 May 2024 | 36,825 | 121,820 (0%) | 0% | 45.4 | 1,670,014 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 36,825 | 0 | - | - | Employee Stock Option (right to buy) | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 89.30 per share. | 02 May 2024 | 29,006 | 84,995 (0%) | 0% | 89.3 | 2,590,236 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 88.86 per share. | 02 May 2024 | 20,000 | 84,995 (0%) | 0% | 88.9 | 1,777,200 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.90 per share. | 02 May 2024 | 7,819 | 114,001 (0%) | 0% | 89.9 | 702,928 | Common Stock |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 388 | 22,587 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 15,607 | 110,469 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.06 per share. | 09 Feb 2024 | 5,474 | 104,995 (0%) | 0% | 81.1 | 443,722 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 2,513 | 93,124 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 2,213 | 95,759 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 1,787 | 94,270 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 1,708 | 91,047 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.50 per share. | 09 Feb 2024 | 897 | 94,862 (0%) | 0% | 81.5 | 73,106 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.50 per share. | 09 Feb 2024 | 724 | 93,546 (0%) | 0% | 81.5 | 59,006 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.50 per share. | 09 Feb 2024 | 641 | 92,483 (0%) | 0% | 81.5 | 52,242 | Common Stock |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.50 per share. | 09 Feb 2024 | 436 | 90,611 (0%) | 0% | 81.5 | 35,534 | Common Stock |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 12,400 | 12,400 | - | - | Restricted Share Unit | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 8,275 | 8,275 | - | - | Restricted Share Unit | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 334 | 7,941 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.06 per share. | 08 Feb 2024 | 334 | 89,339 (0%) | 0% | 81.1 | 27,074 | Common Stock |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 334 | 89,673 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.97 per share. | 31 Dec 2023 | 4,285 | 89,339 (0%) | 0% | 80.0 | 342,671 | Common Stock |
| Centene Corp. | Coughlin Christopher J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 502 | 22,199 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 544 | 21,696 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 75.05 per share. | 25 Aug 2023 | 10,000 | 92,117 (0%) | 0% | 75.1 | 750,500 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 75.31 per share. | 22 Aug 2023 | 10,000 | 102,117 (0%) | 0% | 75.3 | 753,100 | Common Stock |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 543 | 21,152 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 1,904 | 1,904 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 990 | 990 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 2,947 | 20,608 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 260 | 7,615 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.41 per share. | 09 May 2023 | 260 | 112,117 (0%) | 0% | 84.4 | 21,947 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 260 | 112,377 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 510 | 17,661 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.75 per share. | 14 Feb 2023 | 57,475 | 184,592 (0%) | 0% | 27.7 | 1,594,931 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 57,475 | 0 | - | - | Employee Stock Option (right to buy) | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 85.53 per share. | 14 Feb 2023 | 40,797 | 127,117 (0%) | 0% | 85.5 | 3,489,367 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.97 per share. | 14 Feb 2023 | 16,678 | 167,914 (0%) | 0% | 86.0 | 1,433,808 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 85.29 per share. | 14 Feb 2023 | 15,000 | 112,117 (0%) | 0% | 85.3 | 1,279,350 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 13,831 | 128,347 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.41 per share. | 10 Feb 2023 | 4,433 | 123,914 (0%) | 0% | 84.4 | 374,190 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 2,346 | 115,467 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 1,920 | 126,791 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 1,610 | 125,524 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 1,482 | 127,495 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.43 per share. | 10 Feb 2023 | 951 | 114,516 (0%) | 0% | 83.4 | 79,342 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.43 per share. | 10 Feb 2023 | 778 | 126,013 (0%) | 0% | 83.4 | 64,909 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.43 per share. | 10 Feb 2023 | 653 | 124,871 (0%) | 0% | 83.4 | 54,480 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.43 per share. | 10 Feb 2023 | 378 | 127,117 (0%) | 0% | 83.4 | 31,537 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 11,800 | 11,800 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,000 | 113,121 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 7,875 | 7,875 | - | - | Restricted Share Unit | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 407 | 407 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 321 | 321 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 181 | 181 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 67 | 67 | - | - | Option (right to buy) | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 443 | 17,150 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.79 per share. | 29 Dec 2022 | 292 | 105,121 (0%) | 0% | 70.8 | 20,671 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 292 | 105,413 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 292 | 8,558 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.79 per share. | 29 Dec 2022 | 178 | 105,121 (0%) | 0% | 70.8 | 12,601 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 178 | 105,299 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 178 | 5,185 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.79 per share. | 29 Dec 2022 | 166 | 105,121 (0%) | 0% | 70.8 | 11,751 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 166 | 105,287 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 166 | 4,859 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.80 per share. | 29 Dec 2022 | 50 | 105,121 (0%) | 0% | 70.8 | 3,540 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 50 | 105,171 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 50 | 1,482 | - | - | Restricted Share Unit | |
| Timken Co. | Christopher Coughlin | EVP & Pres. Industrial Motion | Sale of securities on an exchange or to another person at price $ 69.29 per share. | 28 Oct 2022 | 15,000 | 103,140 (0%) | 0% | 69.3 | 1,039,350 | Common Stock |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 405 | 16,707 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 10,000 | 118,140 (0%) | 0% | 0 | Common Stock | |
| Prestige Consumer Healthca... | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 2,495 | 13,218 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 436 | 16,301 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 5,000 | - | - | Option (right to buy) | |
| Centene Corp. | Christopher J. Coughlin | Director | Purchase of securities on an exchange or from another person at price $ 81.37 per share. | 29 Apr 2022 | 12,000 | 15,864 (0%) | 0% | 81.4 | 976,440 | Common Stock |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 2,323 | 3,864 (0%) | 0% | 0 | Common Stock | |
| Centene Corp. | Christopher J. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 82.20 per share. | 31 Mar 2022 | 441 | 1,541 (0%) | 0% | 82.2 | 36,250 | Common Stock |
| Timken Co. | Christopher Coughlin | EVP & Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 14,152 | 110,902 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Christopher Coughlin | EVP & Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.07 per share. | 12 Feb 2022 | 4,691 | 106,211 (0%) | 0% | 67.1 | 314,625 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges